Evidence map›Paper›PMID 21250837›Full record

ReviewAutoimmunity2011

Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Liisa K Selin, Myriam F Wlodarczyk, Anke R Kraft, Siwei Nie, Laurie L Kenney, Roberto Puzone, Franco Celada

Open access · greenAbstract readReview
In one paragraph

Review in Autoimmunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. iScience · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Vaccination and heterologous immunity: educating the immune system.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Liisa K SelinDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA. liisa.selin@umassmed.edu
Myriam F Wlodarczyk
Anke R Kraft
Siwei Nie
Laurie L Kenney
Roberto Puzone
Franco Celada
University of Massachusetts Chan Medical School · USNew York University Langone Orthopedic Hospital · US

Funding

Tetramer CoreP01AI049320 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SELIN, LIISA KAARINA · 2001 to 2016
$22.3M
Virology and Technology CoreP01AI046629 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GREINER, DALE LESLIE · 1999 to 2014
$19.1M
PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
UMASS MEDICAL CENTER FOR AIDS RESEARCHP30AI042845 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 1998 to 2012
$13.0M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Immunity and Virus DiseaseR37AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 2004 to 2013
$4.0M
VIRUS-INDUCED IMMUNOPATHOLOGYR01AR035506 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 1986 to 2008
$3.3M
IMMUNITY IN SYSTEMIC AND MUCOSAL VIRUS INFECTIONSR01AI046578 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SELIN, LIISA KAARINA · 2000 to 2009
$3.1M
To model crossreacting T-memory of virus-infected miceR01AI054455 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CELADA, FRANCO · 2003 to 2009
$2.8M
IMMUNITY AND VIRUS DISEASER01AI017672 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WELSH, RAYMOND M · 1985 to 2003
$1.4M
NIAID NIH HHS 5 T32 AI-07349-16NIAID NIH HHS AI-054455NIAID NIH HHS AI17672NIAID NIH HHS AI-42845NIAID NIH HHS AI46578NIAID NIH HHS AI46629NIAID NIH HHS AI-49320NIAID NIH HHS AI49320NIAID NIH HHS P01 AI046629NIAID NIH HHS P01 AI049320NIAID NIH HHS P30 AI042845NIAID NIH HHS R01 AI017672NIAID NIH HHS R01 AI046578NIAID NIH HHS R01 AI054455NIAID NIH HHS R37 AI017672NIAID NIH HHS T32 AI007349NIAMS NIH HHS AR35506NIAMS NIH HHS R01 AR035506NIDDK NIH HHS DK-32520NIDDK NIH HHS P30 DK032520
6 · The paper itself

Abstract

Heterologous immunity is a common phenomenon present in all infections. Most of the time it is beneficial, mediating protective immunity, but in some individuals that have the wrong crossreactive response it leads to a cascade of events that result in severe immunopathology. Infections have been associated with autoimmune diseases such as diabetes, multiple sclerosis and lupus erythematosis, but also with unusual autoimmune like pathologies where the immune system appears dysregulated, such as, sarcoidosis, colitis, panniculitis, bronchiolitis obliterans, infectious mononucleosis and even chronic fatigue syndrome. Here we review the evidence that to better understand these autoreactive pathologies it requires an evaluation of how T cells are regulated and evolve during sequential infections with different pathogens under the influence of heterologous immunity.

Indexed as

AnimalsAutoimmunityHumansImmunityVirus DiseasesViruses

Identifiers

PMID21250837
PMCPMC3633594
OpenAlexW2120886473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.